Bharat Biotech begins clinical trials of TB vaccine on adults in India – Times of India
HYDERABAD: Bharat Biotech International Ltd on Sunday said it started clinical trials of the Tuberculosis vaccine Mtbvac on adults in India. This is the first vaccine against Tuberculosis derived from a human source by the Spanish biopharmaceutical company, Biofabri, a press release from Bharat Biotech said. The release said that Mtbvac is being developed for…
